1887

Journal of General Virology header logo

Volume 83, Issue 11

Vascular endothelial growth factors encoded by show surprising sequence variation but have a conserved, functionally relevant structure Free

Abstract

The first report of a vascular endothelial growth factor (VEGF)-like gene in included the surprising observation that the genes from two isolates (NZ2 and NZ7) shared only 41·1% amino acid sequence identity. We have examined this sequence disparity by determining the VEGF gene sequence of 21 isolates of derived from diverse sources. Most isolates carried NZ2-like VEGF genes but their predicted amino acid sequences varied by up to 30·8% with an average amino acid identity between pairs of NZ2-like sequences of 86·1%. This high rate of sequence variation is more similar to interspecies than intraspecies variability. In contrast, only three isolates carried an NZ7-like VEGF gene and these varied from the NZ7 sequence by no more than a single nucleotide. The VEGF family are ligands for a set of tyrosine kinase receptors. The viral VEGFs are unique among the family in that they recognize VEGF receptor 2 (VEGFR-2) but not VEGFR-1 or VEGFR-3. Comparisons of the viral VEGFs with other family members revealed some correlations between conserved residues and the ability to recognize specific VEGF receptors. Despite the sequence variations, structural predictions for the viral VEGFs were very similar to each other and to the structure determined by X-ray crystallography for human VEGF-A. Structural modelling also revealed that a groove seen in the VEGF-A homodimer and believed to play a role in its binding to VEGFR-1 is blocked in the viral VEGFs. This may contribute to the inability of the viral VEGFs to bind VEGFR-1.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-11-2845
2002-11-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/11/0832845a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-11-2845&mimeType=html&fmt=ahah

References

  1. Chang W., Upton C., Hu S. L., Purchio A. F., McFadden G. 1987; The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Molecular and Cellular Biology 7:535–540
     [Google Scholar]
  2. Cottone R., Buttner M., Bauer B., Henkel M., Hettich E., Rziha H. J. 1998; Analysis of genomic rearrangement and subsequent gene deletion of the attenuated Orf virus strain D1701. Virus Research 56:53–67
     [Google Scholar]
  3. Deane D., McInnes C. J., Percival A., Wood A., Thomson J., Lear A., Gilray J., Fleming S., Mercer A., Haig D. 2000; Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. Journal of Virology 74:1313–1320
     [Google Scholar]
  4. Felsenstein J. 1989; phylip: phylogeny inference package (version 3.2). Cladistics 5:164–166
     [Google Scholar]
  5. Ferrara N. 1999; Vascular endothelial growth factor: molecular and biological aspects. Current Topics in Microbiology and Immunology 237:1–30
     [Google Scholar]
  6. Fleming S. B., Lyttle D. J., Sullivan J. T., Mercer A. A., Robinson A. J. 1995; Genomic analysis of a transposition-deletion variant of orf virus reveals a 3·3 kbp region of non-essential DNA. Journal of General Virology 76:2969–2978
     [Google Scholar]
  7. Fleming S. B., Haig D. M., Nettleton P., Reid H. W., McCaughan C. A., Wise L. M., Mercer A. 2000; Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes 21:85–95
     [Google Scholar]
  8. Gilray J. A., Nettleton P. F., Pow I., Lewis C. J., Stephens S. A., Madeley J. D., Reid H. W. 1998; Restriction endonuclease profiles of orf virus isolates from the British Isles. Veterinary Record 143:237–240
     [Google Scholar]
  9. Guex N., Peitsch M. C. 1997; swiss-model and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723
     [Google Scholar]
  10. Iyer S., Leonidas D. D., Swaminathan G. J., Maglione D., Battisti M., Tucci M., Persico M. G., Acharya K. R. 2001; The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2·0 Å resolution. Journal of Biological Chemistry 276:12153–12161
     [Google Scholar]
  11. Keyt B. A., Nguyen H. V., Berleau L. T., Duarte C. M., Park J., Chen H., Ferrara N. 1996; Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. Journal of Biological Chemistry 271:5638–5646
     [Google Scholar]
  12. Li B., Fuh G., Meng G., Xin X., Gerritsen M. E., Cunningham B., de Vos A. M. 2000; Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization. Journal of Biological Chemistry 275:29823–29828
     [Google Scholar]
  13. Lyttle D. J., Fraser K. M., Fleming S. B., Mercer A. A., Robinson A. J. 1994; Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. Journal of Virology 68:84–92
     [Google Scholar]
  14. McInnes C. J., Wood A. R., Mercer A. A. 1998; Orf virus encodes a homolog of the vaccinia virus interferon-resistance gene E3L. Virus Genes 17:107–115
     [Google Scholar]
  15. McInnes C. J., Wood A. R., Nettleton P. E., Gilray J. A. 2001; Genomic comparison of an avirulent strain of Orf virus with that of a virulent wild type isolate reveals that the Orf virus G2L gene is non-essential for replication. Virus Genes 22:141–150
     [Google Scholar]
  16. Mercer A. A., Haig D. M. 1999; Parapoxviruses. In Encyclopedia of Virology pp 1140–1146 Edited by Granoff A., Webster R. G. London: Academic Press;
     [Google Scholar]
  17. Mercer A. A., Fraser K. F., Barns G., Robinson A. J. 1987; The structure and cloning of orf virus DNA. Virology 157:1–12
     [Google Scholar]
  18. Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J., Augustin H. G., Ziche M., Lanz C., Büttner M., Rziha H.-J., Dehio C. 1999; A novel vascular endothelial growth factor encoded by orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO Journal 18:363–374
     [Google Scholar]
  19. Muller Y. A., Christinger H. W., Keyt B. A., de Vos A. M. 1997a; The crystal structure of vascular endothelial growth factor (VEGF) refined to 1·93 Å resolution: multiple copy flexibility and receptor binding. Structure 5:1325–1338
     [Google Scholar]
  20. Muller Y. A., Li B., Christinger H. W., Wells J. A., Cunningham B. C., de Vos A. M. 1997b; Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proceedings of the National Academy of Sciences, USA 94:7192–7197
     [Google Scholar]
  21. Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., Shibuya M. 1998; A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. Journal of Biological Chemistry 273:31273–31282
     [Google Scholar]
  22. Robinson C. J., Stringer S. E. 2001; The splice variants of vascular endothelial growth factor (VEGF) and their receptors. Journal of Cell Science 114:853–865
     [Google Scholar]
  23. Robinson A. J., Barns G., Fraser K., Carpenter E., Mercer A. A. 1987; Conservation and variation in orf virus genomes. Virology 157:13–23
     [Google Scholar]
  24. Savory L. J., Stacker S. A., Fleming S. B., Niven B. E., Mercer A. A. 2000; Viral vascular endothelial growth factor plays a critical role in orf virus infection. Journal of Virology 74:10699–10706
     [Google Scholar]
  25. Shchelkunov S. N., Safronov P. F., Totmenin A. V., Petrov N. A., Ryazankina O. I., Gutorov V. V., Kotwal G. J. 1998; The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology 243:432–460
     [Google Scholar]
  26. Stacker S. A., Achen M. G. 1999; The vascular endothelial growth factor family: signalling for vascular development. Growth Factors 17:1–11
     [Google Scholar]
  27. Twardzik D. R., Brown J. P., Ranchalis J. E., Todao G. J., Moss B. 1985; Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proceedings of the National Academy of Sciences, USA 82:5300–5304
     [Google Scholar]
  28. Wiesmann C., Fuh G., Christinger H. W., Eigenbrot C., Wells J. A., de Vos A. M. 1997; Crystal structure at 1·7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91:695–704
     [Google Scholar]
  29. Wise L., Veikkola T., Mercer A., Savory L., Fleming S., Caesar C., Vitali A., Makinen T., Alitalo K., Stacker S. 1999; Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR-2 and neuropilin-1. Proceedings of the National Academy of Sciences, USA 96:3071–3076
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-11-2845
Loading
Vascular endothelial growth factors encoded by Orf virus show surprising sequence variation but have a conserved, functionally relevant structure
J. Gen. Virol. 83, 2845 (2002); https://doi.org/10.1099/0022-1317-83-11-2845
/content/journal/jgv/10.1099/0022-1317-83-11-2845
/content/journal/jgv/10.1099/0022-1317-83-11-2845
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error